2663285
SCDGP · Clinical drug group packinfluenza A virus A/Darwin/6/2021 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Darwin/6/2021 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product?
influenza A virus A/Darwin/6/2021 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product is coded as 2663285 in RxNorm.
What is RxNorm code 2663285?
2663285 is the RxNorm identifier for influenza A virus A/Darwin/6/2021 (H3N2) antigen / influenza A virus A/Victoria/4897/2022 (H1N1) antigen / influenza B virus B/Austria/1359417/2021 antigen / influenza B virus B/Phuket/3073/2013 antigen Injectable Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2663285?
2663285 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2663285?
2663285 maps to UMLS C5847089.